Decisional capacity in mental illness and substance use disorders: Empirical database and policy implications

Behavioral Sciences and the Law

Volumn 24, Issue 4, 2006, Pages 607-628

  Jeste, Dilip V ^a,b   Saks, Elyn ^b,c,d  

^a San Diego   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d New Center for Psychoanalysis   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL RESEARCH; COMPETENCE; CONFERENCE PAPER; DECISION MAKING; HEALTH CARE POLICY; HUMAN; MENTAL DISEASE; MENTAL HEALTH; PATIENT PARTICIPATION; PATIENT RIGHT; PSYCHOLOGIC ASSESSMENT; SCHIZOPHRENIA; SCORING SYSTEM; SUBSTANCE ABUSE; TECHNIQUE; TREATMENT PLANNING;

CRIMINAL LAW; DATABASES; DATABASES AS TOPIC; DECISION MAKING; EMPIRICAL RESEARCH; HEALTH POLICY; HUMANS; MENTAL DISORDERS; PUBLIC POLICY; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 33748294146     PISSN: 07353936     EISSN: 10990798     Source Type: Journal    
DOI: 10.1002/bsl.707     Document Type: Conference Paper

References (97)

1. Aaronson, N. K., Visser-Pol, E., Leenhouts, G. H. M. W., Muller, M. J., van der Schot, A. C. M., van Dam, F. S. A. M., Keus, R. B., Koning, C. C. E., ten Bokkel Huinink, W. W., van Dongen, J. A., & Dubbelman, R. (1996). Telephone-based nursing intervention improves the effectiveness of the informed consent process in cancer clinical trials. Journal of Clinical Oncology, 14, 984-996.
2. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC: American Psychiatric Association.
3. Appelbaum, P. S., & Grisso, T. (1995). The MacArthur treatment competence study. I. Mental illness and competence to consent to treatment. Law and Human Behavior, 19, 105-126.
4. Appelbaum, P. S., & Grisso, T. (2001). MacCAT-CR: MacArthur Competence Assessment Tool for Clinical Research. Sarasota, FL: Professional Resource Press.
5. Appelbaum, P. S., Grisso, T., Frank, E., O'Donnell, S., & Kupfer, D. J. (1999). Competence of depressed patients to consent to research. American Journal of Psychiatry, 156, 1380-1384.
6. Appelbaum, P. S., Roth, L. H., & Lidz, C. (1982). The therapeutic misconception: Informed consent in psychiatric research. International Journal of Law and Psychiatry, 5, 319-329.
7. Armstrong, A. P., Cole, A. A., & Page, R. E. (1997). Informed consent: Are we doing enough? British Journal of Plastic Surgery, 50, 637-640.
8. Askew, G., Pearson, K. W., & Cryer, D. (1990). Informed consent: Can we educate patients? Journal of the Royal College of Surgeons of Edinburgh, 35, 308-310.
9. Bean, G., Nishisato, S., Rector, N. A., & Glancy, G. (1994). The psychometric properties of the competency interview schedule. Canadian Journal of Psychiatry, 39, 368-376.
10. Bechara, A., & Damasio, H. (2002). Decision-making and addiction (Part I): Impaired activation of somatic states in substance dependent individuals when pondering decisions with negative future consequences. Neuropsychologia, 40, 1675-1689.
11. Bechara, A., Dolan, S., & Hindes, A. (2002). Decision-making and addiction (Part II): Myopia for the future or hypersensitivity to reward? Neuropsychologia, 40, 1690-1705.
12. Carpenter, W. T., Gold, J. M., Lahti, A. C., Queern, C. A., Conley, R. R., Bartko, J. J., Kovnick, J., & Appelbaum, P. S. (2000). Decisional capacity for informed consent in schizophrenia research. Archives of General Psychiatry, 57, 533-538.
13. Cassileth, B. R., Zupkis, R. V., Sutton-Smith, K., & March, V. (1980). Informed consent - Why are its goals imperfectly realized? New England Journal of Medicine, 302, 896-900.
14. Charland, L. C. (2002). Cynthia's dilemma: Consenting to heroin prescription. American Journal of Bioethics, 2, 37-47.
15. Charland, L. C. (2003). Heroin addicts and consent to heroin therapy: A comment on Hall et al. Addiction, 98, 1633-1636.
16. Cohen, P. J. (2002). Untreated addiction imposes an ethical bar to recruiting addicts for non-therapeutic studies of addictive drugs. Journal of Law, Medicine and Ethics, 30, 73-81.
17. College on Problems of Drug Dependence, & Adler, M. W. (1995). Human subject issues in drug abuse research. Drug and Alchohol Dependence, 37, 167-175.
18. Davis, T. C., Holcombe, R. F., Berkel, H. J., Pramanik, S., & Divers, S. G. (1998). Informed consent for clinical trials: A comparative study of standard versus simplified forms. Journal of the National Cancer Institute, 90, 668-674.
19. DeRenzo, E. G., Conley, R. R., & Love, R. C. (1998). Assessment of capacity to give consent to research participation: State-of-the-art and beyond. Journal of Health Care Law and Policy, 1, 66-87.
20. Dodd, M. J., & Mood, D. W. (1981). Chemotherapy: Helping patients to know the drugs they are receiving and their possible side effects. Cancer Nursing, 4, 311-318.
21. Dolinsky, Z. S., & Babor, T. F. (1997). Ethical, scientific and clinical issues in ethanol administration research involving alcoholics as human subjects. Addiction, 92, 1087-1097.
22. Draper, R. J., & Dawson, D. (1990). Competence to consent to treatment: A guide for the psychiatrist. Canadian Journal of Psychiatry, 35, 285-289.
23. Dunn, L. B., & Jeste, D. V. (2001). Enhancing informed consent for research and treatment. Neuropsychopharmacology, 24, 595-607.
24. Dunn, L. B., & Jeste, D. V. (2003). Problem areas in the understanding of informed consent: Study of middle-aged and older patients with psychotic disorders. Psychopharmacology, 171, 81-85.
25. Dunn, L. B., Lindamer, L. A., Palmer, B. W., Golshan, S., Schneiderman, L. J., & Jeste, D. V. (2002). Improving understanding of research consent in middle-aged and elderly patients with psychotic disorders. American Journal of Geriatric Psychiatry, 10, 142-150.
26. Dunn, L. B., Lindamer, L. A., Palmer, B. W., Schneiderman, L. J., & Jeste, D. V. (2001). Enhancing comprehension of consent for research in older patients with psychosis: A randomized study of a novel educational strategy. American Journal of Psychiatry, 158, 1911-1913.
27. Dunn, L. B., Nowrangi, M. A., Palmer, B. W., Jeste, D. V., & Saks, E. R. (in press). Assessing decisional capacity for clinical research on treatment: A review of instruments. American Journal of Psychiatry.
28. Dymek, M. P., Atchison, P., Harrell, L., & Marson, D. C. (2001). Competency to consent to medical treatment in cognitively impaired patients with Parkinson's disease. Neurology, 56, 17-24.
29. Etchells, E., Darzins, P., Silberfel, M., Singer, P. A., McKenney, J., Naglie, G., Katz, M., Guyatt, G. H., Molloy, W., & Strang, D. (1999). Assessment of patient capacity to consent to treatment. Journal of General Internal Medicine, 14, 27-34.
30. Fitten, L. J., & Waite, M. S. (1990). Impact of medical hospitalization on treatment decision-making capacity in the elderly. Archives of Internal Medicine, 150, 1717-1721.
31. Freckelton, I. (2002). Choice, rationality, and substance dependence. American Journal of Bioethics, 2, 60-61.
32. Goldman-Rakic, P. S. (1994). Working memory dysfunction in schizophrenia. Journal of Neuropsychiatry and Clinical Neurosciences, 6, 348-357.
33. Grant, S., Contoreggi, C., & London, E. D. (2000). Drug abusers show impaired performance in a laboratory test of decision making. Neuropsychologia, 38, 1180-1187.
34. Green, M. F. (1996). What are the functional consequences of neurocognitive deficits in schizophrenia? American Journal of Psychiatry, 153, 321-330.
35. Green, M. F., Kern, R. S., Braff, D. L., & Mintz, J. (2000). Neurocognitive deficits and functional outcome in schizophrenia: Are we measuring the "right stuff"? Schizophrenia Bulletin, 26, 119-136.
36. Grisso, T., & Appelbaum, P. S. (1995). The MacArthur Treatment Competence Study. III. Abilities of patients to consent to psychiatric and medical treatments. Law and Human Behavior, 19, 149-174.
37. Grisso, T., & Appelbaum, P. S. (1998a). Assessing Competence to Consent to Treatment: A Guide for Physicians and Other Health Professionals. New York: Oxford University Press.
38. Grisso, T., Appelbaum, P. S., & Hill-Fotouhi, C. (1997). The MacCAT-T: A clinical tool to assess patients' capacities to make treatment decisions. Psychiatric Services, 48, 1415-1419.
39. Grisso, T., Appelbaum, P. S., Mulvey, E. P., & Fletcher, K. (1995). The MacArthur Treatment Competence Study. II. Measures of abilities related to competence to consent to treatment. Law and Human Behavior, 19, 127-148.
40. Hall, W., Morley, L. C., & Morley, K. I. (2003). Addiction, neurosciences and ethics. Addiction, 98, 867-870.
41. Hazelton, L. D., Sterns, G. L., & Chisholm, T. (2003). Decision-making capacity and alcohol abuse: Clinical and ethical considerations in personal care choices. General Hospital Psychiatry, 25, 130-135.
42. Howard, J. M., DeMets, D., & the BHAT Research Group. (1981). How informed is consent? The BHAT experience. Controlled Clinical Trials, 2, 287-303.
43. Janofsky, J. S., McCarthy, R. J., & Folstein, M. F. (1992). The Hopkins Competency Assessment Test: A brief method for evaluating patients' capacity to give informed consent. Hospital and Community Psychiatry, 43, 132-136.
44. Jeste, D. V. (2003a). Enhancing comprehension of consent for research in older persons with psychosis. APA Annual Meeting.
45. Jeste, D. V. (2003b). Predictors and enhancement of decisional capacity in schizophrenia. AGNP Annual Meeting.
46. Jeste, D. V., Depp, C. A., & Palmer, B. W. (2006). Magnitude of impairment in decisional capacity in people with schizophrenia compared to normal subjects: An overview. Schizophrenia Bulletin, 32, 121-128.
47. Jeste, S. D., Patterson, T. L., Palmer, B. W., Dolder, C. R., Goldman, S., & Jeste, D. V. (2003). Cognitive predictors of medication adherence among middle aged and older outpatients with schizophrenia. Schizophrenia Research, 63, 49-58.
48. Joffe, S., Cook, E. F., Clearly, P. D., Clark, J. W., & Weeks, J. C. (2001). Quality of informed consent: A new measure of understanding among research subjects. Journal of the National Cancer Institute, 93, 139-147.
49. Karlawish, J. H., Casarett, D. J., & James, B. D. (2002). Alzheimer's disease patients' and caregivers' capacity, competency, and reasons to enroll in an early-phase Alzheimer's disease clinical trial. Journal of the American Geriatrics Society, 50, 2019-2024.
50. Kim, S. Y. H., Caine, E. D., Currier, G. W., Leibovici, A., & Ryan, J. M. (2001). Assessing the competence of persons with Alzheimer's Disease in providing informed consent for participation in research. American Journal of Psychiatry, 158, 712-717.
51. Kleiman, M. (2003). The 'Brain Disease' idea, drug policy and research ethics. Addiction, 98, 871-874.
52. Kleinman, I., Schachter, D., Jeffries, J., & Goldhamer, P. (1993). Effectiveness of two methods for informing schizophrenia patients about neuroleptic medication. Hospital and Community Psychiatry, 44, 1189-1191.
53. Kleinman, I., Schachter, D., Jeffries, J., & Goldhamer, P. (1996). Informed consent and tardive dyskinesia: Long-term follow-up. Journal of Nervous and Mental Disease, 184, 517-522.
54. Kovnick, J. A., Appelbaum, P. S., Hoge, S. K., & Leadbetter, R. A. (2003). Competence to consent to research among long-stay inpatients with chronic schizophrenia. Psychiatric Services, 54, 1247-1252.
55. Krynski, M. D., Tymchuck, A. J., & Ouslander, J. G. (1994). How informed can consent be?: New light on comprehension among elderly people making decisions about enteral tube feeding. Gerontologist, 34, 36-43.
56. Lane, S. D., & Cherek, D. R. (2000). Analysis of risk taking in adults with a history of high risk behavior. Drug and Alcohol Dependence, 60, 179-187.
57. Ling, W. (2002). Cynthia's dilemma. American Journal of Bioethics, 2, 55-56.
58. Marson, D. C., Chatterjee, A., Ingram, K. K., & Harrell, L. E. (1996). Toward a neurological model of competency: Cognitive predictors of capacity to consent in Alzheimer's disease using three different legal standards. Neurology, 46, 666-672.
59. Marson, D., & Harrell, L. (1999). Executive dysfunction and loss of capacity to consent to medical treatment in patients with Alzheimer disease. Seminars in Clinical Neuropsychiatry, 4, 41-49.
60. Marson, D. C., Hawkins, L., McInturff, B., & Harrell, L. E. (1997). Cognitive models that predict physician judgments of capacity to consent in mild Alzheimer's disease. Journal of the American Geriatrics Society, 45, 458-464.
61. Marson, D. C., Ingram, K. K., Cody, H. A., & Harrell, L. E. (1995). Assessing the competency of patients with Alzheimer's disease under different legal standards. Archives of Neurology, 52, 949-954.
62. McLeod, C. (2002). Authenticity and the hijacked brain. American Journal of Bioethics, 2, 62-63.
63. McNeil, T. F. (1987). A prospective study of postpartum psychoses in a high-risk group. Acta Psychiatrica Scandinavica, 75, 35-43.
64. Miller, C. K., O'Donnell, D., Searight, R., & Barbarash, R. A. (1996). The Deaconess Informed Consent Comprehension Test: An assessment tool for clinical research subjects. Pharmacotherapy, 16, 872-878.
65. Morrow, G., Gootnick, J., & Schmale, A. (1978). A simple technique for increasing cancer patients' knowledge of informed consent to treatment. Cancer, 42, 793-799.
66. Moser, D., Schultz, S., & Arndt, S. (2002). Capacity to provide informed consent for participation in schizophrenia and HIV research. American Journal of Psychiatry, 159, 1201-1207.
67. Palmer, B. W., Dunn, L. B., Appelbaum, P. S., & Jeste, D. V. (2004). Correlates of treatment-related decision-making capacity among middle-aged and older patients with schizophrenia. Archives of General Psychiatry, 61, 230-236.
68. Palmer, B. W., & Jeste, D. V. (2006). Relationship of individual cognitive abilities to specific components of decisional capacity among middle-aged and older patients with schizophrenia. Schizophrenia Bulletin, 32, 98-106.
69. Paulus, M. P., Hozack, N., Frank, L., Brown, G. G., & Schuckit, M. A. (2003). Decision making by methamphetamine-dependent subjects is associated with error-rate-independent decrease in prefrontal and parietal activation. Biological Psychiatry, 53, 65-74.
70. Paulus, M. P., Hozack, N. E., Zauscher, B. E., Frank, L., Brown, G. G., Braff, D. L., & Schuckit, M. A. (2002). Behavioral and functional neuroimaging evidence for prefrontal dysfunction in methamphet-amine-dependent subjects. Neuropsychopharmacology, 26, 53-63.
71. Raich, P. C., Plomer, K. D., & Coyne, C. A. (2001). Literacy, comprehension, and informed consent in clinical research. Cancer Investigation, 19, 437-445.
72. Reynolds, C. R., Chastain, R. L., Kaufman, A. S., & McLean, J. E. (1987). Demographic characteristics and IQ among adults: Analysis of the WAIS-R standardization sample as a function of the stratification variables. Journal of School Psychology, 25, 323-342.
73. Rikkert, M. G. M. O., van den Bercken, J. H. L., ten Have, H. A. M. J., & Hoefnagels, W. H. L. (1997). Experienced consent in geriatrics research: A new method to optimize the capacity to consent in frail elderly subjects. Journal of Medical Ethics, 23, 271-276.
74. Roberts, L. W. (2002a). Addiction and consent. American Journal of Bioethics, 2, 58-60.
75. Roberts, L. W. (2002b). Informed consent and the capacity for voluntarism. American Journal of Psychiatry, 159, 705-712.
76. Roberts, L. W., & Roberts, B. (1999). Psychiatric research ethics: An overview of evolving guidelines and current ethical dilemmas in the study of mental illness. Biological Psychiatry, 46, 1025-1038.
77. Roberts, L. W., Warner, T. D., & Brody, J. L. (2000). Perspectives of patients with schizophrenia and psychiatrists regarding ethically important aspects of research participation. American Journal of Psychiatry, 157, 67-74.
78. Roberts, L. W., Warner, T. D., Brody, J. L., Roberts, B., Lauriello, J., & Lyketsos, C. (2002). Patient and psychiatrist ratings of hypothetical schizophrenia research protocols: Assessment of harm potential and factors influencing participation decisions. American Journal of Psychiatry, 159, 573-584.
79. Robinson, D. G., Woerner, M. G., Ma, J., Alvir, J. M., Bilder, R. M., Hinrichsen, G. A., & Lieberman, J. A. (2002). Predictors of medication discontinuation by patients widi first-episode schizophrenia and schizoaffective disorder. American Journal of Psychiatry, 57, 209-219.
80. Rosoff, A. J. (1999). Informed consent in the electronic age. American Journal of Law and Medicine, 25, 367-386.
81. Roth, L. H., Lidz, C. W., Meisel, A., Soloff, P. H., Kaufman, K., Spiker, D. G., & Foster, F. G. (1982). Competency to decide about treatment or research: An overview of some empirical data. International Journal of Law and Psychiatry, 5, 29-50.
82. Saks, E. R. (1999 March). Competency to decide on treatment and research: The MacArthur capacity instruments. In National Bioethics Advisory Commission, Research Involving Persons with Mental Disorders That May Affect Decisionmaking Capacity, Vol. II, Commissioned Papers (pp. 59-78). Rockville, MD: National Bioethics Advisory Commission.
83. Saks, E. R., Dunn, L. B., Marshall, B. J., Nayak, G. V., Golshan, S., & Jeste, D. V. (2002). The California Scale of Appreciation: A new instrument to measure the appreciation component of capacity to consent to research. American Journal of Geriatric Psychiatry, 10, 166-174.
84. Stanley, B., Guido, J., Stanley, M., & Shortell, D. (1984). The elderly patient and informed consent: Empirical findings. Journal of the American Medical Association, 252, 1302-1306.
85. Stanley, B., Stanley, M., Guido, J., & Garvin, L. (1988). The functional competency of elderly at risk. Gerontologist, 28, 53-58.
86. Stiles, P. G., Poythress, N. G., Hall, A., Falkenbach, D., & Williams, R. (2001). Improving under-standing of research consent disclosures among persons with mental illness. Psychiatric Services, 52, 780-785.
87. Taub, H. A., Baker, M. T., Kline, G. E., & Sturr, J. F. (1987). Comprehension of informed consent information by young-old through old-old volunteers. Experimental Aging Research, 13, 173-178.
88. Taub, H. A., Baker, M. T., & Sturr, J. F. (1986). Informed consent for research: Effects of readability, patient age, and education. Journal of the American Geriatrics Society, 34, 601-606.
89. Taub, H. A., Kline, G. E., & Baker, M. T. (1981). The elderly and informed consent: Effects of vocabulary level and corrected feedback. Experimental Aging Research, 7, 137-146.
90. Tomoda, A., Yasumiya, R., Sumiyama, T., Tsukada, K., Hayakawa, T., Matsubara, K., Kitamura, F., & Kitamura, T. (1997). Validity and reliability of structured interview for competency incompetency assessment testing and ranking inventory. Journal of Clinical Psychology, 53, 443-450.
91. Tymchuk, A. J., & Ouslander, J. G. (1991). Informed consent: Does position of information have an effect upon what elderly people in long-term care remember? Educational Gerontology, 17, 11-19.
92. Tymchuk, A. J., Ouslander, J. G., Rahbar, B., & Fitten, J. (1988). Medical decision-making among elderly people in long term care. Gerontologist, 28 (Suppl.), 59-63.
93. Uhl, G. R. (2003). Are over-simplified views of addiction neurosciences providing too simplified ethical considerations? Addiction, 98, 871-874.
94. Wadey, V., & Frank, C. (1997). The effectiveness of patient verbalization on informed consent. Canadian Journal of Surgery, 40, 124-128.
95. Weston, J., Hannah, M., & Downes, J. (1997). Evaluating the benefits of a patient information video during the informed consent process. Patient Education and Counseling, 30, 239-245.
96. White, C. S., Mason, A. C., Feehan, M., & Templeton, P. A. (1995). Informed consent for percutaneous lung biopsy: Comparison of two consent protocols based on patient recall after the procedure. American Journal of Roentgenology, 165, 1139-1142.
97. Wirshing, D. A., Wirshing, W. C., Marder, S. R., Liberman, R. P., & Mintz, J. (1998). Informed consent: Assessment of comprehension. American Journal of Psychiatry, 155, 1508-1511.